NCT03352245View on ClinicalTrials.gov

Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 26, 2018

Primary Completion Date

May 24, 2020

Study Completion Date

May 24, 2020

Conditions
Lung Neoplasm Malignant
Interventions
BEHAVIORAL

Prescribed Activity

Educational session at enrollment, increase subject communication via tailored electronic messaging, and use of a wrist-bound device (FitBit Flex 2)

Trial Locations (1)

06510

Yale University, New Haven

All Listed Sponsors
collaborator

Medical University of South Carolina

OTHER

collaborator

VA Connecticut Healthcare System

FED

collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER

NCT03352245 - Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer | Biotech Hunter | Biotech Hunter